CAL-101 is under clinical development by Calluna Pharma and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to GlobalData, Phase I drugs for Plaque Psoriasis (Psoriasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback